Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST
Radiopharm Theranostics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -55.15 | -38.34 | -47.95 | -34.61 | -30.42 |
Depreciation & Amortization | 2.71 | 2.6 | 3.13 | 3.3 | 2.98 |
Loss (Gain) From Sale of Assets | - | - | 1.69 | - | - |
Asset Writedown & Restructuring Costs | - | - | 1.48 | - | - |
Stock-Based Compensation | - | 1.9 | 2.64 | 3.04 | 4.8 |
Other Operating Activities | -0.34 | 3.16 | 8.99 | 1.13 | 10.48 |
Change in Accounts Receivable | - | -9.41 | 3.48 | 1.51 | -0.05 |
Change in Accounts Payable | - | 0.51 | 3.5 | 2.35 | 2.53 |
Change in Other Net Operating Assets | - | 2.95 | 0.07 | 0.1 | -0.23 |
Operating Cash Flow | -52.78 | -36.65 | -22.98 | -23.2 | -9.91 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | - | - | - | -0.05 | -0 |
Sale (Purchase) of Intangibles | - | 3 | - | -1.49 | -28.34 |
Investment in Securities | - | - | - | - | -0.04 |
Other Investing Activities | -5.42 | -1.23 | -0.32 | - | - |
Investing Cash Flow | -5.42 | 1.77 | -0.32 | -1.53 | -28.38 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | - | - | - | 0.01 |
Long-Term Debt Issued | - | - | 7.37 | - | - |
Total Debt Issued | - | - | 7.37 | - | 0.01 |
Short-Term Debt Repaid | - | - | - | - | -0.07 |
Long-Term Debt Repaid | - | -1.9 | -5.17 | - | - |
Total Debt Repaid | - | -1.9 | -5.17 | - | -0.07 |
Net Debt Issued (Repaid) | - | -1.9 | 2.2 | - | -0.06 |
Issuance of Common Stock | 35.38 | 53.98 | 29.65 | 10.07 | 70 |
Other Financing Activities | -2 | -6.65 | -1.65 | -0.85 | -4.83 |
Financing Cash Flow | 33.37 | 45.43 | 30.2 | 9.22 | 65.11 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.15 | -0.01 | -0.03 | 0.23 | 0.13 |
Net Cash Flow | -24.98 | 10.54 | 6.88 | -15.28 | 26.95 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -52.78 | -36.65 | -22.98 | -23.25 | -9.91 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -390.92% | -292.88% | -1173.12% | -374.36% | - |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.06 | -0.08 | -0.06 |
Levered Free Cash Flow | -30.74 | -23.62 | -12.04 | -12.08 | -31.35 |
Unlevered Free Cash Flow | -30.67 | -23.57 | -11.64 | -12.03 | -25.51 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Income Tax Paid | -4.49 | - | -4.85 | -1.56 | - |
Change in Working Capital | - | -5.95 | 7.05 | 3.95 | 2.25 |